These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10786314)

  • 1. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
    Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
    Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
    Toyama K; Yaguchi M; Uchida Y; Suzuki K; Sawanobori M; Ikeda Y; Matsuoka S; Wakasugi K; Furuya T; Oshimi K; Kawamata N; Kikuchi M; Murakami H; Tsuruoka N; Tomoyasu S; Kawaguchi M; Hirosawa S; Yamamoto K; Shirota T; Harada Y; Dan K; Yamada T; Kawano K; Onozawa Y; Takeuchi J
    Jpn J Antibiot; 1999 Feb; 52(2):153-61. PubMed ID: 10221180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M; Hirashima K
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
    Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
    Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
    Sawae Y; Niho Y; Okamura T; Gondo H; Kozuru M; Uike N; Muta K; Goto T; Suehiro Y; Kumakawa M; Nishimura J; Yufu Y; Ishikura H; Yamashita S; Hisano S; Morioka E; Nakajima H; Shibuya T; Yamasaki K; Harada N; Asayama R; Hayashi S; Akashi K; Suematsu E; Kawasaki C
    Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
    Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
    Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
    Uno N; Nosaka T; Uchiyama S; Kawakami K; Hoshino K; Mori M; Hotta Y; Ohta C; Kobayashi T; Kita K
    Jpn J Antibiot; 1987 Mar; 40(3):469-75. PubMed ID: 3613072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    Hasegawa S; Nakao I
    Jpn J Antibiot; 1984 Sep; 37(9):1631-6. PubMed ID: 6512982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
    Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.